Eterna Therapeutics Inc (NASDAQ:ERNA) currently has a daily average trading volume of 10.18M but it saw 17479508 shares traded in last market. With a market cap of 22.39M USD, the company’s current market price of $0.44 came falling about -4.85 while comparing to the previous closing price of $0.46. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.62 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.381 while lowest mark touched by it was $0.5187.
Taking a look at 20-day trading activity of Eterna Therapeutics Inc (ERNA) gives us an average price of $0.3053, while its current price level is -83.40% below from 52-week high level whereas it is 97.02% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5165 while that of 200 days or SMA-200 reads an average of $1.4268. A closer look into the stock’s movement over the week reveals that its volatility is standing at 38.81% during that period while stretching the period over a month that decreases to 21.94%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 56.96 which implies that the stock is in neutral territory.
Over the week, ERNA’s stock price is moving 30.71% up while it is 50.38% when we observe its performance for the past one month. Year-to-date it is 48.23% up and over the past year, the stock is showing a downside performance of -75.10%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Eterna Therapeutics Inc’s total number of outstanding shares is 51.37M with 336.35% of that held by the insiders while 11.00% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1154.18%. Stock’s beta reads 4.27. Stock has a price to sale or P/S ratio amounts to 37.32. Its return on asset (ROA) is -149.86% on average.
